Kimmtrak® (tebentafusp-tebn)
for Skin Cancer

Kimmtrak (tebentafusp-tebn) is a prescription medicine used to treat HLA-A*02:01-positive adults with uveal melanoma that cannot be removed by surgery or has spread. As a monoclonal antibody, tebentafusp works by targeting cancer cells, helping to slow or stop their growth, and providing treatment for this specific type of melanoma.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Skin Cancer